Pharmacological prevention of acute mountain sickness

The prevention of acute mountain sickness – the effect of theophylline and acetazolamide in prevention of acute mountain sickness

Efficacy and harm of pharmacological prevention of acute mountain sickness: quantitative systematic review.

OBJECTIVE To quantify efficacy and harm of pharmacological prevention of acute mountain sickness. DATA SOURCES Systematic search (Medline, Embase, Cochrane Library, internet, bibliographies, authors) in any language, up to October 1999. STUDY SELECTION Randomised placebo controlled trials. DATA EXTRACTION Dichotomous data on efficacy and harm from 33 trials (523 subjects received 13 diffe...

Side-effect of acetazolamide in prevention of acute mountain sickness.

March 2012, Vol. 102, No. 3 SAMJ 2. Sky News. Bahrain docs face jail despite torture claims. 22 November 2011. http://news.sky.com/ home/world-news/article/16115007 (accessed 17 January 2012). 3. Baldwin-Ragaven L, de Gruchy J, London L. An Ambulance of the Wrong Colour. Health Professionals, Human Rights and Ethics in South Africa. Cape Town: UCT Press, 1999. 4. Gray B, Ockelford P. Bahrain he...

Magnesium for the prevention and treatment of acute mountain sickness.

Magnesium is a physiological N-methyl-D-aspartate (NMDA) antagonist. The NMDA receptor may be involved in the pathogenesis of acute mountain sickness (AMS). In the present study, healthy subjects were randomized to receive either 400 mg of oral magnesium citrate (16 mmol) or matching placebo every 8 h for 5 days (prevention trial). Subjects then climbed to 4559 m in approx. 24 h and stayed ther...

Severe acute mountain sickness.

The experiences of acute mountain sickness (AMS) as it has presented to a physician working in a general hospital at 1370 m in Kathmandu, nepal, are described. The features of 39 cases are analysed. It is suggested that AMS should be classified into benign and malignant forms.